ID   NCC-GCTB8-C1
AC   CVCL_D4C0
RX   DOI=10.21203/rs.3.rs-3457371/v1;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 26 hours (DOI=10.21203/rs.3.rs-3457371/v1).
CC   Sequence variation: Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (DOI=10.21203/rs.3.rs-3457371/v1).
CC   Derived from site: In situ; Bone, right proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): DOI=10.21203/rs.3.rs-3457371/v1
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 31,32.2
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   DOI=10.21203/rs.3.rs-3457371/v1;
RA   Adachi Y., Noguchi R., Yoshimatsu Y., Sin Y., Osaki J., Ono T.,
RA   Iwata S., Akiyama T., Tsuchiya R., Toda Y., Ishihara S., Ogura K.,
RA   Kobayashi E., Kojima N., Yoshida A., Yokoo H., Kawai A., Kondo T.;
RT   "Establishment and characterization of two novel patient-derived cell
RT   lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.";
RL   Res. Sq. 2023:3457371-3457371(2023).
//